Six Out Of 7M People With J&J Vaccine Developed Rare Blood Clots
Six Out Of 7M People With J&J Vaccine Developed Rare Blood Clots

Federal health officials in the United States are pressing pause on administering Johnson & Johnson’s COVID-19 vaccine following rare reports of blood clots in people who received the shot.